Cargando…

Hospitalizations for Cardiovascular Diseases During the Early Stage of the COVID-19 Pandemic in Japan

Background: Although reductions in hospitalizations for myocardial infarction and heart failure have been reported during the period of COVID-19 pandemic restrictions, it is unclear how the overall number of hospitalizations for cardiovascular disease (CVD) treatment changed in the early stages of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sugimoto, Tadafumi, Mizuno, Atsushi, Yoneoka, Daisuke, Matsumoto, Shingo, Matsumoto, Chisa, Matsue, Yuya, Ishida, Mari, Nakai, Michikazu, Iwanaga, Yoshitaka, Miyamoto, Yoshihiro, Node, Koichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Circulation Society 2022
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360987/ https://www.ncbi.nlm.nih.gov/pubmed/36032385 http://dx.doi.org/10.1253/circrep.CR-22-0058

Ejemplares similares

Cardiovascular Hospitalizations and Hospitalization Costs in Japan During the COVID-19 Pandemic
por: Sugimoto, Tadafumi, et al.
Publicado: (2023)

Cardiology Department Practices in the First Wave of the Coronavirus Disease Pandemic　― A Nationwide Survey in Japan by the Japanese Circulation Society―
por: Mizuno, Atsushi, et al.
Publicado: (2021)

Joint Declaration on COVID-19 by the Japan Stroke and Japanese Circulation Societies
por: Kishi, Takuya, et al.
Publicado: (2020)

Relationship Between Official Twitter Ambassadors and the Number of Retweets in the Annual Congress　― “Tweet the Meeting” ―
por: Mizuno, Atsushi, et al.
Publicado: (2021)

Impact of Tweet Content on the Number of Retweets　― “Tweet the Meeting 2022” ―
por: Suzuki, Takahiro, et al.
Publicado: (2023)

Cardiology Department Policy in Japan After Coronavirus Disease-2019 (COVID-19)　― Descriptive Summary of 2nd Nationwide Survey by the Japanese Circulation Society ―
por: Mizuno, Atsushi, et al.
Publicado: (2021)

Two-Year Experience in “Tweeting the Meeting” During the Scientific Sessions　― Rapid Report From the Japanese Circulation Society ―
por: Mizuno, Atsushi, et al.
Publicado: (2020)

Potential Role of Twitter at an Annual Congress in Japan　― Narrative Literature Review of “Tweet the Meeting” ―
por: Mizuno, Atsushi, et al.
Publicado: (2019)

Prevalence and temporal trends of prostate diseases among inpatients with cardiovascular disease: a nationwide real-world database survey in Japan
por: Kaneta, Kohei, et al.
Publicado: (2023)

Quality indicators for acute cardiovascular diseases: a scoping review
por: Kanaoka, Koshiro, et al.
Publicado: (2022)

Combination of coronary CT angiography, FFR(CT), and risk factors in the prediction of major adverse cardiovascular events in patients suspected CAD
por: Wada, Shinichi, et al.
Publicado: (2023)

Reduction in Planned Percutaneous Coronary Interventions After the Policy Change for Ischemia Assessment in Japan
por: Kanaoka, Koshiro, et al.
Publicado: (2023)

Impact of body mass index on in-hospital mortality for six acute cardiovascular diseases in Japan
por: Yoshida, Naofumi, et al.
Publicado: (2022)

Impact of body mass index on the outcome of Japanese patients with cardiovascular diseases and/or risk factors hospitalized with COVID-19 infection
por: Saito, Takafumi, et al.
Publicado: (2022)

Sex Differences in Clinical Outcomes Among Patients With COVID-19 and Cardiovascular Disease　― Insights From the CLAVIS-COVID Registry ―
por: Matsumoto, Shingo, et al.
Publicado: (2022)

Predictive value of neutrophil-to-lymphocyte ratio for the fatality of COVID-19 patients complicated with cardiovascular diseases and/or risk factors
por: Higaki, Akinori, et al.
Publicado: (2022)

External validation of the 4C Mortality Score for patients with COVID-19 and pre-existing cardiovascular diseases/risk factors
por: Kuroda, Shunsuke, et al.
Publicado: (2021)

Incidence Rate of Hospitalization for Heart Failure in a Japanese City　― An Updated Reference for Japan’s Aging Society ―
por: Marume, Kyohei, et al.
Publicado: (2022)

Etiology and Outcome of Ischemic Stroke in Patients With Renal Impairment Including Chronic Kidney Disease: Japan Stroke Data Bank
por: Miwa, Kaori, et al.
Publicado: (2022)

Development of a Cardiovascular Disease Risk Prediction Model Using the Suita Study, a Population-Based Prospective Cohort Study in Japan
por: Nakai, Michikazu, et al.
Publicado: (2020)

Assessment of thromboembolism risk in COVID-19 patients with cardiovascular disease risk factors: Analysis of a Japanese Nationwide Registry()
por: Shibahashi, Eiji, et al.
Publicado: (2022)

Association of PM(2.5) exposure with hospitalization for cardiovascular disease in elderly individuals in Japan
por: Kaihara, Toshiki, et al.
Publicado: (2021)

Impact of serum lactate dehydrogenase on the short-term prognosis of COVID-19 with pre-existing cardiovascular diseases
por: Masumoto, Akiko, et al.
Publicado: (2022)

Comparison of care and outcomes for myocardial infarction by heart failure status between United Kingdom and Japan
por: Nakao, Kazuhiro, et al.
Publicado: (2023)

Clinical Significance of Atrial Fibrillation Status in Patients With Percutaneous Coronary Intervention
por: Hamaguchi, Toka, et al.
Publicado: (2021)

Intensive Care Unit Admission for Moderate-to-Severe COVID-19 Patients With Known Cardiovascular Diseases or Their Risk Factors　― Insights From a Nationwide Japanese Cohort Study ―
por: Yoshida, Naofumi, et al.
Publicado: (2021)

Effect of Inferior Vena Cava Filter on Venous Thromboembolism Mortality in Japan　― JROAD and JROAD-DPC Registry Analysis ―
por: Ohyama, Yoshiaki, et al.
Publicado: (2019)

Number of Cardiologists per Cardiovascular Beds and In‐Hospital Mortality for Acute Heart Failure: A Nationwide Study in Japan
por: Kanaoka, Koshiro, et al.
Publicado: (2019)

Interconnection between cardiovascular, renal and metabolic disorders: A narrative review with a focus on Japan
por: Kadowaki, Takashi, et al.
Publicado: (2022)

Clinical application of glucagon-like peptide-1 receptor agonists in cardiovascular disease: lessons from recent clinical cardiovascular outcomes trials
por: Tanaka, Atsushi, et al.
Publicado: (2018)

Increased amputation risk with canagliflozin treatment: behind the large cardiovascular benefit?
por: Tanaka, Atsushi, et al.
Publicado: (2017)

Differences in patient characteristics, clinical practice and outcomes of cardiac implantable electric device therapy between Japan and the USA: a cross-sectional study using data from nationally representative administrative databases
por: Tonegawa-Kuji, Reina, et al.
Publicado: (2023)

Effectiveness of nationwide screening and lifestyle intervention for abdominal obesity and cardiometabolic risks in Japan: The metabolic syndrome and comprehensive lifestyle intervention study on nationwide database in Japan (MetS ACTION-J study)
por: Nakao, Yoko M., et al.
Publicado: (2018)

Collective Knowledge Used to Unveil Cardiovascular Injury Emerged during COVID-19
por: Tanaka, Atsushi, et al.
Publicado: (2022)

Satisfaction Survey for Regional Clinical Pathway for Stroke Patients in Acute and Rehabilitation Hospitals in Japan
por: Wada, Shinichi, et al.
Publicado: (2023)

How should we monitor the cardiovascular benefit of sodium–glucose cotransporter 2 inhibition?
por: Tanaka, Atsushi, et al.
Publicado: (2020)

Associations among cardiovascular and cerebrovascular diseases: Analysis of the nationwide claims-based JROAD-DPC dataset
por: Nakai, Michikazu, et al.
Publicado: (2022)

A lower maximum bite force is a risk factor for developing cardiovascular disease: the Suita study
por: Hashimoto, Sakae, et al.
Publicado: (2021)

Relationship Between Heart Failure Hospitalization Costs and Left Ventricular Ejection Fraction in an Advanced Aging Society
por: Kaichi, Ryota, et al.
Publicado: (2021)

Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors
por: Tanaka, Atsushi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ansj46hkjpeh0nv7j2cjpsovl9